All Updates

All Updates

icon
Filter
Partnerships
Recursion Pharmaceuticals partners with Helix to accelerate drug discovery through AI and genomic data
AI Drug Discovery
Jun 24, 2024
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Product updates
Microsoft launches Copilot Actions for workplace automation
Foundation Models
Yesterday
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
AI Drug Discovery

AI Drug Discovery

Jun 24, 2024

Recursion Pharmaceuticals partners with Helix to accelerate drug discovery through AI and genomic data

Partnerships

  • Utah-based AI biotech company Recursion Pharmaceuticals has entered a multi-year agreement with precision medicine genomic solutions provider Helix, to accelerate drug discovery using population health data and AI.

  • According to the agreement, Recursion will gain the rights to use de-identified clinico-genomic data provided by Helix, collected from consenting research participants across the US. It plans to use the obtained data to train its AI models to create biomarkers and form strategies for patient stratification across multiple diseases

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.